Document is current
Any future updates will be listed below
-
Authors
Bidzinska, Joanna https://orcid.org/0000-0003-3890-5473
Di Pietro, Lorenzo
Naghshineh, Eisa https://orcid.org/0000-0003-2858-6042
Pandini, Cecilia
Doria, Filippo https://orcid.org/0000-0002-1308-1060
Zaffaroni, Nadia https://orcid.org/0000-0002-4669-0890
Gandellini, Paolo https://orcid.org/0000-0002-7811-3377
Neidle, Stephen https://orcid.org/0000-0003-0622-6548
Folini, Marco https://orcid.org/0000-0002-1811-4407
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG 2019 - ID.22933 (M. Folini), Pre-doc fellowship for Italy (E. Naghshineh))
- License Information
-
More Information
Article History
Received: 11 November 2024
Revised: 27 June 2025
Accepted: 21 July 2025
First Online: 1 August 2025
Competing interests
: SN is currently a member of the Scientific Advisory Board of Qualigen Therapeutics Inc.
: All methods were carried out in accordance with relevant guidelines and regulations. This study did not involve live vertebrates or human participants; therefore, informed consent and ethics committee approval were not required.
